EU investigates cholesterol-lowering drugs
The European Medicines Evaluation Agency (EMEA) announced that an advisory panel will conduct a safety review of statins, the most commonly used type of cholesterol-lowering drugs. The move comes one day after Bayer withdrew its cholesterol treatment Baycol, a drug used by six million people worldwide, because of reports linking 31 deaths among patients taking the drug in the United States.
The European Medicines Evaluation Agency (EMEA) announced that an advisory panel will conduct a safety review of statins, the most commonly used type of cholesterol-lowering drugs. The move comes one day after Bayer withdrew its cholesterol treatment Baycol, a drug used by six million people worldwide, because of reports linking 31 deaths among patients taking the drug in the United States.